$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
7 Dividend Increases Expected In April 2026
04:58am, Friday, 03'rd Apr 2026
April 2026 is poised for dividend increases from blue-chip names with long records of annual hikes. Procter & Gamble (PG), Johnson & Johnson (JNJ), IBM, Apple, Kinder Morgan, W.W. Grainger, and Costco
Archford Capital Strategies LLC Buys 11,548 Shares of Johnson & Johnson $JNJ
03:14am, Friday, 03'rd Apr 2026
Archford Capital Strategies LLC raised its stake in Johnson and Johnson (NYSE: JNJ) by 85.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Excha
JNJ Q1 MedTech Preview: Key Drivers and China Headwinds to Watch
11:06am, Thursday, 02'nd Apr 2026
JNJ's MedTech unit rides cardiovascular strength and new product adoption, but China headwinds loom ahead of its Q1 earnings release.
The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income
08:10am, Thursday, 02'nd Apr 2026
With inflation back in the economic picture, simply getting a dependable income stream may not be the best strategy for Boomer and Gen X retirees.
This Healthcare Stock Barely Flinches During Market Sell-Offs
06:14am, Thursday, 02'nd Apr 2026
Johnson & Johnson is a reliable dividend payer and has a solid revenue pipeline. It achieved 51 drug approvals and 15 new med-tech launches in 2025.
Stagflation Fears Are Back: These 3 Stocks Can Help You Ride Out the Storm
04:44am, Thursday, 02'nd Apr 2026
ExxonMobil should enable investors to profit from the primary source of stagflation. Johnson & Johnson and Walmart sell products that people need regardless of what happens with the economy.
Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Wednesday, 01'st Apr 2026
Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 01'st Apr 2026
Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.
Volatility Is Spiking. Here Are 3 Dividend Stocks You Can Buy Without Hesitation.
03:45am, Wednesday, 01'st Apr 2026
Johnson & Johnson has a stronger credit rating than the U.S. government. PepsiCo's brand loyalty gives it considerable pricing power.
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
04:15pm, Tuesday, 31'st Mar 2026
Global development program for JNJ-1900 (NBTXR3) proceeded as planned, building toward opportunity to address one of the largest untapped markets in oncology through lead programs in head and neck can
The Dividend King That's Raised Its Payout for 63 Consecutive Years
01:30pm, Tuesday, 31'st Mar 2026
Johnson & Johnson is a Dividend King. The company's strong operations suggest regular payout increases aren't a thing of the past.
Why Johnson & Johnson Is Rebounding — Finally
12:53pm, Tuesday, 31'st Mar 2026
Johnson & Johnson stock is Tuesday's IBD Stock Of The Day. After years of sideways trade, J&J stock began a bullish streak last year.
Here's Why You Don't Bet Against This Dividend King
11:30am, Tuesday, 31'st Mar 2026
Markets have delivered plenty of twists lately, with inflation cooling but growth uneven and volatility still lurking around every earnings corner.
My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 12 Buys
08:15am, Tuesday, 31'st Mar 2026
In February, I focused almost exclusively on beaten-down BDCs like Ares Capital, Owl Rock Capital, and Hercules Capital amid macroeconomic turmoil. The portfolio's average yield on cost for new invest
Extreme Fear is Gripping the Market, This Is the Smart Move Most Investors Miss.
08:09am, Tuesday, 31'st Mar 2026
The markets are in no mood for risk. The CNN Fear & Greed Index sits at 13 — firmly in Extreme Fear — after previously closing at 8, its lowest level since 2022, when Terraform Labs and its algori
Sign In
Buy JNJ